Aignostics secures $34 million Series B to improve precision medicine with AI

Investments will support new product offerings, US expansion, and development of pathology foundation models

05-Nov-2024 - Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, ...

Start-up aims to accelerate bioprocess development

IRUBIS secures pre-series A funding led by BioProcess360 Partners

02-Sep-2024 - Biotech startup IRUBIS, developing a state-of-the-art real-time bioprocess monitoring solution, has successfully closed a pre-series A funding round. The financing round was led by BioProcess360 Partners, with participation from previous investors such as High-Tech Gründerfonds (HTGF), Verve ...

Hong Kong firm invests in Jena-based Oncgnostics GmbH

12-Sep-2023 - The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a seven-digit Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics has developed the cancer diagnostic Gyntect for the reliable detection of cervical cancer. Since 2022, this test has also been ...

Precision diagnostics to immune medicine using AI-assisted analysis of single-cell blood data

hema.to raises €3.6M

20-Jul-2023 - hema.to’s mission is to make the clinical analysis of blood data — called cytometry — automated and fully objective to enable personalization of treatment to every person’s unique immune system. Currently, even for skilled laboratory personnel, cytometry analysis is a laborious process that has a ...

DNTOX receives €1.4 million seed funding for non-animal testing of chemicals

The new capital will be used to set up the test laboratories in Düsseldorf, aim for GLP accreditation and launch the test battery on the market

20-Jun-2023 - The Life Science startup DNTOX receives seed funding of €1.4 million. The round is led by HTGF, with private investors Barbara Korte-Sturm and Nikolaus Sturm as well as Bool Capital and AQAL Capital also participating. The Düsseldorf-based company has developed a test system based on human cells ...

Diagnosing cancer in minutes

Identify tumour margins directly in the surgery room: Refined Laser Systems raises €2.7m

30-Jan-2023 - Refined Laser Systems, a dynamic biophotonics company specialised in pioneering laser systems for SRS-microscopy and quantum technology, today announces a Seed funding round of €2.7 million led by High-Tech Gründerfonds and APEX Ventures, along with NRW.BANK, Onsight Ventures and Papst Venture ...

Aignostics Raises €14m Series A to Advance AI-powered Pathology

Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases

19-Sep-2022 - Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, today announced the closing of an oversubscribed €14m Series A financing round. Wellington Partners led the round, ...

C-mo Medical Solutions raises €4.1 million aiming to transform cough monitoring

14-Sep-2022 - C-mo Medical Solutions is an award-winning start-up that is unravelling the potential of assessing cough towards improved diagnosis, treatment courses and disease management. The company has now raised 4.1€Mn in a seed round led by Boehringer Ingelheim Venture Fund. This investment will allow the ...

First commercial Quantum Microscope

Swiss start-up Qnami closes 4.0M CHF Series A financing round

14-May-2021 - Qnami announced today the closing of a 4.0M CHF (4.4M USD) Series A financing round led by Venture Capital funds Runa Capital and SIT Capital, further supported by Seed Round investors Quantonation, Verve Ventures, ZKB Start-up Finance and the High-Tech Gründerfonds. The funds will support ...

New separation technology for biomolecules

i3 Membrane receives 7 figure sum for development and market launch

26-Jan-2021 - Four investors are financing the further growth of i3 Membrane GmbH. High-tech venture capital investor HTGF from Bonn, Germany, and three private investors are together investing a 7 figure sum in the further development and market launch of new separation technology for biological molecules. ...